title: Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway.
abstract: We sought to assess the effect of progestin on the apoptosis of epithelial ovarian cancer cell line SKOV-3 and via regulation of phosphorylation signaling in. Epithelial ovarian cancer cell line SKOV-3 was treated with medroxyprogestogen, phosphatidylinositol 3-kinase inhibitor LY294002 and vehicle control. Akt, phospho-Akt, Bcl-2 and phospho-Bad proteins were examined by immunoblotting assays. Medroxyprogestogen-induced apoptosis was assessed by MTT assays and Annexin V apoptosis assay. We found no significant difference in Akt and Bad expression in both the medroxyprogestogen groups and the control group. The levels of phospho-Akt, Bcl-2 and phospho-Bad were decreased in all the medroxyprogestogen groups and significantly decreased in the high dose mitogen-activated protein (MAP) group (10 µmol/L). Viability of SKOV-3 was reduced and apparent apoptosis of SKOV-3 cells was observed with increased doses of MAP. The findings suggest that medroxyprogestogen can induce SKOV-3 cell apoptosis by inhibiting Akt phosphorylation.
authors.affiliation: Department of Gynecology and Obstetrics, the First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu 210029, China;
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Yi
authors.initials: Y
authors.lastname: Jiang
authors.forename: Yicong
authors.initials: Y
authors.lastname: Wan
authors.forename: Lin
authors.initials: L
authors.lastname: Zhang
authors.forename: Weiwei
authors.initials: W
authors.lastname: Tang
authors.forename: Jingjing
authors.initials: J
authors.lastname: Ma
authors.forename: Shan
authors.initials: S
authors.lastname: Wu
authors.forename: Wenjun
authors.initials: W
authors.lastname: Cheng
keywords: Akt; apoptosis; medroxyprogestogen; ovarian cancer; phosphorylation
references.citation: Science. 1997 Oct 24;278(5338):687-9
references.pmid: 9381178
references.citation: Int J Oncol. 2008 Nov;33(5):959-67
references.pmid: 18949358
references.citation: Obstet Gynecol Clin North Am. 2000 Dec;27(4):705-21
references.pmid: 11091985
references.citation: Clin Breast Cancer. 2003 Jun;4(2):126-37
references.pmid: 12864941
references.citation: Cancer Res. 2009 Dec 1;69(23):8910-7
references.pmid: 19903849
references.citation: Oncogene. 2007 Feb 26;26(9):1324-37
references.pmid: 17322918
references.citation: J Biol Chem. 2001 Jul 13;276(28):26461-71
references.pmid: 11346642
references.citation: Cell. 1997 Oct 17;91(2):231-41
references.pmid: 9346240
references.citation: Dev Cell. 2002 Nov;3(5):631-43
references.pmid: 12431371
references.citation: Cell. 1995 Jan 27;80(2):285-91
references.pmid: 7834748
references.citation: Gynecol Oncol. 2003 Mar;88(3):394-9
references.pmid: 12648592
references.citation: Int J Gynecol Cancer. 2009 May;19(4):620-7
references.pmid: 19509560
references.citation: Nat Rev Cancer. 2009 Jul;9(7):501-7
references.pmid: 19550425
references.citation: Cancer Res. 2003 Jan 1;63(1):196-206
references.pmid: 12517798
references.citation: Clin Exp Metastasis. 2002;19(3):265-73
references.pmid: 12067207
references.citation: J Clin Oncol. 2004 Mar 1;22(5):909-18
references.pmid: 14990647
references.citation: J Natl Cancer Inst. 2002 Jan 2;94(1):32-8
references.pmid: 11773280
references.citation: J Biol Chem. 2002 Mar 29;277(13):11107-15
references.pmid: 11799110
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Gynecol Oncol. 2009 Apr;113(1):99-104
references.pmid: 19178934
references.citation: J Biol Chem. 2002 May 17;277(20):17638-48
references.pmid: 11884391
references.citation: J Steroid Biochem Mol Biol. 2001 Aug;78(2):185-91
references.pmid: 11566443
references.citation: J Clin Oncol. 2004 Jun 15;22(12):2336-47
references.pmid: 15136596
references.citation: Oncogene. 2000 Nov 9;19(47):5385-97
references.pmid: 11103940
references.citation: Dev Cell. 2002 Nov;3(5):607-8
references.pmid: 12431365
references.citation: Gynecol Oncol. 2007 Feb;104(2):470-9
references.pmid: 17070899
references.citation: Science. 1999 Nov 12;286(5443):1358-62
references.pmid: 10558990
references.citation: Cancer Res. 2005 Aug 15;65(16):7338-47
references.pmid: 16103085
references.citation: Br J Cancer. 1995 Jun;71(6):1340-2
references.pmid: 7779735